View
Page
Panmure note from Research Tree... We make some slight changes to our Aveva forecasts in the wake of the analyst 'surgery' on Friday last. Whilst the surgery contained little new news, it helped to clarify our thinking. As we suspected, no special dividend, as Aveva would prefer to retain cash for a potential acquisition. There is also a CMD in the early stages of being planned, think early Autumn, then Aveva will discuss its product plans for its cloud initiative. Finally it was a positive that the management team seems to have a better grasp on its markets.
Latest from the Community...
Latest from the Community...
Latest from the Community...
